285 related articles for article (PubMed ID: 34479513)
1. Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves's disease: a case report and literature review.
Zeng J; Luo F; Lin Z; Chen Y; Wang X; Song Y
BMC Endocr Disord; 2021 Sep; 21(1):179. PubMed ID: 34479513
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
3. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
4. An unusual evolution of thyroid function after therapeutic plasma exchange in Graves' disease with cholestatic jaundice: A case report.
Jin Y; Feng X; Ni H
Medicine (Baltimore); 2024 Feb; 103(8):e37074. PubMed ID: 38394504
[TBL] [Abstract][Full Text] [Related]
5. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
[No Abstract] [Full Text] [Related]
7. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
8. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
9. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report.
Zheng M; Cui S; Zhang W; Brigstock DR; Gao R
BMC Gastroenterol; 2022 Feb; 22(1):59. PubMed ID: 35144533
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves' disease patients.
Li X; Jin S; Fan Y; Fan X; Tang Z; Cai W; Yang J; Xiang X
Biomed Pharmacother; 2019 Sep; 117():109095. PubMed ID: 31202168
[TBL] [Abstract][Full Text] [Related]
12. [Methimazole and propylthiouracil induced acute toxic hepatitis].
Casallo Blanco S; Valero MA; Marcos Sánchez F; de Matías Salces L; Blanco González JJ; Martín Barranco MJ
Gastroenterol Hepatol; 2007 May; 30(5):268-70. PubMed ID: 17493435
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and early effectiveness of methimazole in patients with graves' hyperthyroidism-related severe hepatic dysfunction.
Li C; Wang KL; Hu JH; Su HB
Scand J Gastroenterol; 2023; 58(12):1514-1522. PubMed ID: 37545358
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
Sato H; Minagawa M; Sasaki N; Sugihara S; Kazukawa I; Minamitani K; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y
J Pediatr Endocrinol Metab; 2011; 24(5-6):257-63. PubMed ID: 21823520
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
[TBL] [Abstract][Full Text] [Related]
16. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
17. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic examination of methimazole-induced hepatotoxicity in patients with Grave's disease: a metabolomic approach.
Li X; Yang J; Jin S; Dai Y; Fan Y; Fan X; Li Z; Yang J; Yau WP; Lin H; Cai W; Xiang X
Arch Toxicol; 2020 Jan; 94(1):231-244. PubMed ID: 31740989
[TBL] [Abstract][Full Text] [Related]
19. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
20. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.
Sato I; Tsunekawa T; Shinohara Y; Nishio Y; Shimizu Y; Suzuki Y; Yoshioka S
Nagoya J Med Sci; 2011 Aug; 73(3-4):205-9. PubMed ID: 21928702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
